IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a large market cap stock with a market cap of 10034.07. It is in the Diagnostic Substances industry and sector Healthcare, with a current P/E of 51.12, a forward P/E of 41.93 and EPS of 2.21. At a stock price of 112.92 (-0.01%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 11.60%, more recently this last year it has grown by 14.40%. The next year growth is going to be about 14.06% and more long-term 14.35% after five years. EPS growth quarter over quarter is 22.60%. Sales growth for the past five years have been 7.70% and sales growth quarter over quarter is 12.90%.
For performance, IDEXX Laboratories, Inc. the past week has seen a gain of -0.43%. For the last month performance for IDEXX Laboratories, Inc. is -0.90%. While the last quarter is 20.31% and half year, 40.31%. Finally for the year, performance is 57.49%.
The 52-week high for IDEXX Laboratories, Inc., is at -1.86%, and for the 52-week low it comes to a value of 77.88%. The 20-day simple moving average is 3.25% and 28.95% for the 200-day simple moving average.
Volatility for the week is at 1.36%, and for the month it is 1.61%. IDEXX Laboratories, Inc., has a target price of 116.8.
In terms of debt, long term debt/equity is *TBA, and for total debt/equity IDEXX Laboratories, Inc. has *TBA. The gross margin is 55.00%, while operating margin is 18.70%, the profit margin is 11.90%. The current ratio is 1 and the quick ratio is 0.8.
Insider ownership is at 1.30%, with instituitional ownership at 95.10%. IDEXX Laboratories, Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 88.86. The shares float is 88.25, with the float short at 4.23%, with short ratio coming to 7.67.
In terms of returns, the return on assets see IDEXX Laboratories, Inc., get 13.60%, with its returns on investment at 22.10%. Return on equity is -392.60%. So will the investors see the target price of 116.8, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.